Sample Transport Optimization: Mali Pilot Study.


Journal

Health security
ISSN: 2326-5108
Titre abrégé: Health Secur
Pays: United States
ID NLM: 101654694

Informations de publication

Date de publication:
Jan 2020
Historique:
entrez: 1 2 2020
pubmed: 1 2 2020
medline: 6 10 2020
Statut: ppublish

Résumé

In Mali, qualified laboratories for testing of dangerous pathogens are centralized in Bamako. Creating a specimen transport system respecting timeline, specimen quality, biosafety, and biosecurity standards is a challenge. The current ad hoc system that relies on untrained public transport companies carries risks of spoilage, accidental release of pathogens, and delays, which compromise specimen quality. This pilot study aimed to evaluate the effectiveness (ie, timeline, quality of specimen, and cost) of using the trained postal service for sample transportation from district to central level, compared with the current system. The postal service intervention ran from mid-2016 to mid-2017 and covered 3 districts. Data were collected in the same districts during the same period of the preceding year for comparison. In all, 41 specimens were shipped using public transportation and 51 were shipped using the postal service. These included suspected meningitis, measles, yellow fever, and polio samples. Only 46% of samples sent by public transportation were received in Bamako within 72 hours of collection, compared to 71% of samples shipped via the postal service (

Identifiants

pubmed: 32004128
doi: 10.1089/hs.2019.0061
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S92-S97

Auteurs

Hamadoun Kassambara (H)

Hamadoun Kassambara, MPH, is Chief of Party, GHSA, and Mamadou Diango Traoré, MS, is Data Manager, GHSA; both in the Department of Health, Catholic Relief Services, Bamako, Mali.Marjorie Larson Nana, MPH, is a Program Officer, Johns Hopkins Center for Communications Programs, Johns Hopkins University, Baltimore, MD.Famory Samassa, MPH, is Senior Technical Advisor for Health, Management Science for Health, Bamako, Mali. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.

Marjorie Larson Nana (ML)

Hamadoun Kassambara, MPH, is Chief of Party, GHSA, and Mamadou Diango Traoré, MS, is Data Manager, GHSA; both in the Department of Health, Catholic Relief Services, Bamako, Mali.Marjorie Larson Nana, MPH, is a Program Officer, Johns Hopkins Center for Communications Programs, Johns Hopkins University, Baltimore, MD.Famory Samassa, MPH, is Senior Technical Advisor for Health, Management Science for Health, Bamako, Mali. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.

Famory Samassa (F)

Hamadoun Kassambara, MPH, is Chief of Party, GHSA, and Mamadou Diango Traoré, MS, is Data Manager, GHSA; both in the Department of Health, Catholic Relief Services, Bamako, Mali.Marjorie Larson Nana, MPH, is a Program Officer, Johns Hopkins Center for Communications Programs, Johns Hopkins University, Baltimore, MD.Famory Samassa, MPH, is Senior Technical Advisor for Health, Management Science for Health, Bamako, Mali. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.

Mamadou Diango Traoré (MD)

Hamadoun Kassambara, MPH, is Chief of Party, GHSA, and Mamadou Diango Traoré, MS, is Data Manager, GHSA; both in the Department of Health, Catholic Relief Services, Bamako, Mali.Marjorie Larson Nana, MPH, is a Program Officer, Johns Hopkins Center for Communications Programs, Johns Hopkins University, Baltimore, MD.Famory Samassa, MPH, is Senior Technical Advisor for Health, Management Science for Health, Bamako, Mali. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH